相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans. Part A: Use of FDA post-market reports to create a database of hepatobiliary and urinary tract toxicities
Carling J. Ursem et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2009)
Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicities
Edwin J. Matthews et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2009)
Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part C: Use of QSAR and an expert system for the estimation of the mechanism of action of drug-induced hepatobiliary and urinary tract toxicities
Edwin J. Matthews et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2009)
Structure-activity relationship analysis tools: Validation and applicability in predicting carcinogens
J. Mayer et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2008)
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models
Naomi L. Kruhlak et al.
TOXICOLOGY MECHANISMS AND METHODS (2008)
Combined use of MC4PC, MDL-QSAR, BioEpisteme, leadscope PDM, and derek for windows software to achieve high-performance, high-confidence, mode of action-based predictions of chemical carcinogenesis in rodents
Edwin J. Matthews et al.
TOXICOLOGY MECHANISMS AND METHODS (2008)
Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling
Luis G. Valerio et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2007)
A comprehensive model for reproductive and developmental toxicity hazard identification: I. Development of a weight of evidence QSAR database
Edwin J. Matthews et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2007)
Focus on success: using a probabilistic approach to achieve an optimal balance of compound properties in drug discovery
Matt D. Segall et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
In silico screening of chemicals for bacterial mutagenicity using electrotopological E-state indices and MDL QSAR software
JF Contrera et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2005)
The use of structure-activity relationship analysis in the food contact notification program
AB Bailey et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2005)
Models of steroid binding based on the minimum deviation of structurally assigned 13C NMR spectra analysis (MiDSASA)
RD Beger et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2004)
Building predictive models for protein tyrosine phosphatase 1B inhibitors based on discriminating structural features by reassembling medicinal chemistry building blocks
CH Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Finding discriminating structural features by reassembling common building blocks
KP Cross et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
ADME-Tox in drug discovery: integration of experimental and computational technologies
HS Yu et al.
DRUG DISCOVERY TODAY (2003)
Structure-activity relationship approaches and applications
W Tong et al.
ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY (2003)
Tumor classification by partial least squares using microarray gene expression data
DV Nguyen et al.
BIOINFORMATICS (2002)
LeadScope: Software for exploring large sets of screening data
G Roberts et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2000)
分享论文
